comparemela.com
Home
Live Updates
Has Immunotherapy Found Its Place in Pancreatic Cancer? : comparemela.com
Has Immunotherapy Found Its Place in Pancreatic Cancer?
A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.
Related Keywords
United States ,
North Carolina ,
American ,
Zeva Wainberg ,
,
American Association For Cancer Research ,
Duke University In Durham ,
University Of California Los Angeles ,
California Los Angeles ,
American Association ,
Cancer Research ,
Annual Meeting ,
Duke University ,
Malignant Pancreatic Neoplasm ,
Pancreatic Cancer ,
Ancer Of The Pancreas ,
Biologic Therapy ,
Iologics ,
Cancer ,
Alignant Neoplasia ,
Arcinoma ,
Alignant Neoplasm ,
Neoadjuvant ,
Immunotherapy ,
Surgery ,
Presection ,
Tumor ,
Chemotherapy ,
Adverse Effects ,
Side Effects ,
California ,
Cd4 ,
Luster Of Differentiation 4 ,
Luster Of Differentiation 4 Cd4 ,
Fellowship ,
Yellows ,
Fistula ,
Patient Safety ,
comparemela.com © 2020. All Rights Reserved.